Wells Fargo & Company Kiniksa Pharmaceuticals, Ltd. Transaction History

Wells Fargo & Company

$434 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$17.63 - $21.74 $34,625 - $42,697	1,964 Added 18.54%	12,559 $247,000
Q4 2023 Feb 09, 2024	SELL	$14.37 - $19.07 $335,927 - $445,799	-23,377 Reduced 68.81%	10,595 $185,000
Q3 2023 Nov 13, 2023	BUY	$13.62 - $20.2 $13,878 - $20,583	1,019 Added 3.09%	33,972 $590,000
Q2 2023 Aug 15, 2023	BUY	$10.44 - $16.48 $32,061 - $50,610	3,071 Added 10.28%	32,953 $463,000
Q1 2023 May 12, 2023	BUY	$10.7 - $15.79 $310,171 - $457,720	28,988 Added 3242.51%	29,882 $321,000
Q4 2022 Feb 13, 2023	SELL	$11.42 - $17.05 $3,688 - $5,507	-323 Reduced 26.54%	894 $13,000
Q3 2022 Nov 14, 2022	SELL	$9.76 - $13.41 $3,074 - $4,224	-315 Reduced 20.56%	1,217 $16,000
Q2 2022 Aug 12, 2022	SELL	$7.6 - $11.41 $17,951 - $26,950	-2,362 Reduced 60.66%	1,532 $15,000
Q1 2022 May 16, 2022	SELL	$9.3 - $12.37 $95,129 - $126,532	-10,229 Reduced 72.43%	3,894 $39,000
Q4 2021 Feb 14, 2022	SELL	$10.39 - $15.15 $49,892 - $72,750	-4,802 Reduced 25.37%	14,123 $166,000
Q3 2021 Nov 15, 2021	SELL	$11.39 - $16.23 $156,168 - $222,529	-13,711 Reduced 42.01%	18,925 $216,000
Q2 2021 Aug 16, 2021	SELL	$13.22 - $19.09 $1.15 Million - $1.66 Million	-87,057 Reduced 72.73%	32,636 $455,000
Q1 2021 May 13, 2021	BUY	$16.68 - $23.97 $791,933 - $1.14 Million	47,478 Added 65.75%	119,693 $2.22 Million
Q4 2020 Feb 09, 2021	BUY	$14.8 - $21.15 $337,617 - $482,473	22,812 Added 46.18%	72,215 $1.28 Million
Q3 2020 Nov 05, 2020	BUY	$15.21 - $25.53 $140,190 - $235,310	9,217 Added 22.94%	49,403 $756,000
Q2 2020 Aug 13, 2020	BUY	$15.08 - $26.0 $459,879 - $792,896	30,496 Added 314.72%	40,186 $1.02 Million
Q1 2020 May 14, 2020	BUY	$11.0 - $19.76 $106,590 - $191,474	9,690 New	9,690 $150,000

Others Institutions Holding KNSA

# of Institutions

Shares Held

1.95M

Call Options Held

Put Options Held

Pictet Asset Management Sa Geneva 73, V8

1.52M
Shares

$33.1 Million
0.03% of portfolio
Spearhead Capital Advisors, LLC Wellington, FL

203K
Shares

$4.42 Million
2.82% of portfolio
Harbor Capital Advisors, Inc.

97.5K
Shares

$2.13 Million
0.11% of portfolio
Putnam Investments LLC Boston, MA

39.5K
Shares

$860,794
0.0% of portfolio
Birchview Capital, LP Burlington, VT

30K
Shares

$654,000
0.69% of portfolio

View Full List

About Kiniksa Pharmaceuticals, Ltd.

Ticker KNSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,470,400
Market Cap $751M
Description
Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...

More about KNSA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account